VEGFA and neoplasm: Increased expression of proangiogenic factors such as VEGF-A, fibroblast growth factor (FGF), and angiopoietin 1 leads to the phenotypic transformation of tumor ECs, a phenomenon called endothelial anergy, making them resistant to immune cell infiltration, particularly cytotoxic CD8+ T cells.